ClairDGBeachJM.Mesenteric ischemia. N Engl J Med. 2016;374:959-968. doi:10.1056/NEJMra1503884
2.
RosendaalFRCannegieterSCvan der MeerFJBriëtE.A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239.
3.
OwensJPMirtalloJMMurphyCC.Oral anticoagulation in patients with short-bowel syndrome. DICP. 1990;24:585-589.
4.
BrophyDFFordSLCrouchMA.Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy. 1998;18:646-649. doi:10.1002/j.1875-9114.1998.tb03129.x
5.
SobierajDMWangFKirtonOC.Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy. Pharmacotherapy. 2008;28:1537-1541. doi:10.1592/phco.28.12.1537
6.
StrongATSharmaGNor HanipahZet al. Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2018;14:700-706.
7.
LutomskiDM.Warfarin, short bowel syndrome, and intravenous lipids. Pharmacotherapy. 1998;18:1375-1376. doi:10.1002/j.1875-9114.1998.tb03163.x
